Literature DB >> 2069388

Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin.

D M Shlaes1, L Etter, L Gutmann.   

Abstract

Using both high and low inocula for time-kill curves, we examined the antibiotic killing of clinical isolates of glycopeptide-resistant enterococci (Enterococcus faecium, E. faecalis, and E. gallinarum) belonging to phenotypic resistance classes A, B, and C. None were resistant to high levels (greater than 500 mg/liter) of gentamicin. Vancomycin-penicillin-gentamicin resulted in 2 or more logs of killing above that of the most effective two-antibiotic combination for all strains except two of three E. gallinarum (VanC) strains and a constitutive mutant of a VanB strain. This strategy may be useful clinically.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2069388      PMCID: PMC245099          DOI: 10.1128/AAC.35.4.776

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Use of penicillin-binding proteins for the identification of enterococci.

Authors:  R Williamson; L Gutmann; T Horaud; F Delbos; J F Acar
Journal:  J Gen Microbiol       Date:  1986-07

2.  Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256.

Authors:  S al-Obeid; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

3.  Inducible, transferable resistance to vancomycin in Enterococcus faecium, D399.

Authors:  D M Shlaes; S Al-Obeid; J H Shlaes; A Boisivon; R Williamson
Journal:  J Antimicrob Chemother       Date:  1989-04       Impact factor: 5.790

Review 4.  Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s.

Authors:  R C George; A H Uttley
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

5.  Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

6.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

7.  Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis.

Authors:  R C Moellering; O M Korzeniowski; M A Sande; C B Wennersten
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

8.  Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci.

Authors:  R Leclercq; E Bingen; Q H Su; N Lambert-Zechovski; P Courvalin; J Duval
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

9.  Self-transferable plasmids determining the hemolysin and bacteriocin of Streptococcus faecalis var. zymogenes.

Authors:  A E Jacob; G J Douglas; S J Hobbs
Journal:  J Bacteriol       Date:  1975-03       Impact factor: 3.490

10.  Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256.

Authors:  D M Shlaes; A Bouvet; C Devine; J H Shlaes; S al-Obeid; R Williamson
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

View more
  32 in total

Review 1.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

2.  Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci.

Authors:  A Ferrara; C Dos Santos; M Cimbro; G Gialdroni Grassi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

Review 3.  Treatment options for vancomycin-resistant enterococcal infections.

Authors:  Peter K Linden
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate.

Authors:  L L Carias; S D Rudin; C J Donskey; L B Rice
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

5.  Synergy and resistance to synergy between beta-lactam antibiotics and glycopeptides against glycopeptide-resistant strains of Enterococcus faecium.

Authors:  L Gutmann; S al-Obeid; D Billot-Klein; M L Guerrier; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

6.  Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations.

Authors:  M Green; B Binczewski; A W Pasculle; M Edmund; K Barbadora; S Kusne; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

7.  Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium.

Authors:  F Caron; M D Kitzis; L Gutmann; A C Cremieux; B Maziere; J M Vallois; A Saleh-Mghir; J F Lemeland; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

8.  Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  I R Friedland; M Paris; S Ehrett; S Hickey; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

9.  A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci.

Authors:  H S Gold; S Unal; E Cercenado; C Thauvin-Eliopoulos; G M Eliopoulos; C B Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

10.  Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.

Authors:  M K Hayden; G I Koenig; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.